jarrett disbrow  arbor pharmaceuticals llc  zoominfocom bizapediacom  human validation companiespeopleproductsservicestrademarksaddressesphone book our system has detected a high number of page requests from your ip address please prove to us that you are a human to continue using our website please send me to the search subscription offer page after i successfully answer the word challenge bizapediapro searchperform unlimited searches via ouradvanced search form withbizapedia pro searchfind out more bizapediapro databuild custom data listsfor one or many stateswith bizapedia pro datafind out more  copyright   · bizapediacom · all rights reservedblogpro searchpro apicontact usterms of useprivacy policysitemapdesktop version bizapediacom  human validation companiespeopleproductsservicestrademarksaddressesphone book our system has detected a high number of page requests from your ip address please prove to us that you are a human to continue using our website please send me to the search subscription offer page after i successfully answer the word challenge bizapediapro searchperform unlimited searches via ouradvanced search form withbizapedia pro searchfind out more bizapediapro databuild custom data listsfor one or many stateswith bizapedia pro datafind out more  copyright   · bizapediacom · all rights reservedblogpro searchpro apicontact usterms of useprivacy policysitemapdesktop version jarrett t disbrow phd executive profile  biography  bloomberg july    am et pharmaceuticals company overview of aytu bioscience inc snapshotpeople  overviewboard memberscommittees executive profile jarrett t disbrow phdchief operating officer aytu bioscience incagetotal calculated compensationthis person is connected to  board members in  different organizations across  different industriesas of fiscal year  background mr jarrett t disbrow phd has been the chief operating officer of aytu bioscience inc since april   mr disbrow served as secretary and treasurer at rosewind corp since april   mr disbrow served as secretary and treasurer of aytu bioscience inc he served as the chief executive officer and president at vyrix pharmaceuticals inc from november  to april   he joined vyrix pharmaceuticals from eurus pharma llc or eurus pharma where  he held the position of general manager from  to  he founded arbor pharmaceuticals inc in april  and served as its president chief executive officer and vice president of commercial development prior to founding arbor pharmaceuticals in  he served as head of marketing for accentia biopharmaceuticals inc from  to  mr disbrow has a decade of experience in the pharmaceutical industry focused on successful product commercialization prior to arbor he served as the head of marketing at teamm pharmaceuticals where he was responsible for the launch and marketing of several key products along with helping to build its product pipeline he was also a member of the senior management team of teamm directly involved in all areas of its commercialization he began his career with glaxowellcom inc nowglaxosmithkline plc from  to  where he held positions of increasing responsibility in sales and later marketing including being a part of the advair® brand marketing team he served as a director of aytu bioscience inc from january   to july   he served as a director at vyrix pharmaceuticals inc from november  to april   mr disbrow received a bs in business management from north carolina state university in raleigh ncread full background corporate headquarters  inverness parkwayenglewood colorado united statesphone fax  board members memberships there is no board members memberships data available education bs north carolina state university other affiliations north carolina state universityarbor pharmaceuticals llcrosewind corpvyrix pharmaceuticals inc annual compensation salarybonustotal annual compensation stocks options unexercisable optionstotal number of options total compensation total annual cash compensationtotal short term compensationtotal calculated compensation request profile update   the information and data displayed in this profile are created and managed by sp global market intelligence a division of sp global bloombergcom does not create or control the content for inquiries please contact sp global market intelligence directly by clicking here stock quotes market data is delayed at least  minutes company lookup competitor compensationthere is no competitor compensation data available sponsored financial commentaries sponsored links browse companies a b c d e f g h i j k l m n o p q r s t u v w x y z              request profile update only a company representative may request an update for the company profile documentation will be required to contact aytu bioscience inc please visit  company data is provided by sp global market intelligence please use this form to report any data issues information missing  please enter your information in the following fields company name your name your email address your phone number type of data overview executives key developments similar companies transactions update needed all data changes require verification from public sources please include the correct value or values and a source where we can verify cancel submit your requested update has been submitted our data partners will research the update request and update the information on this page if necessary research and followup could take several weeks if you have questions you can contact them at bwwebmasterbusinessweekcom close microsoft personalized ad preferences to opt out of personalized ads in this browser your browser history must allow firstparty and thirdparty cookies and you must have your browsing experience set to not delete browsing history on exit instructions for enabling cookies and configuring your browsing history may be available in your browsers settings privacy or help documentation sign in hold on… we’re sorry but this didn’t work you can’t turn off personalized ads right now because your browser is currently blocking thirdparty cookies we can help you fix this issue let’s get started depending on what browser you use open options or settings make sure that thirdparty cookies are not blocked anymore to find out how search your browser’s help revisit httpchoicemicrosoftcomoptout and then on the “personalized ads in this browser” tile click off ext about our ads to create a more customized online experience some of the ads you may receive on microsoft websites and apps are tailored to your previous activities searches and site visits youre in control and heres where you can make the advertising choice thats right for you ext where can i learn more about advertising on microsoft websites and apps microsoft partners with oath appnexus and other third party service providers to help present customized content and display advertisements on msn outlookcom and other websites and apps microsoft also delivers search ads to bing and our search syndication partners learn more about microsoft’s privacy practices here you can learn more about interestbased ads from oath and appnexus in their privacy statements oath and appnexus what choices do i have about interestbased advertising on this page you can opt out of receiving interest based advertising from microsoft you can also opt out of receiving interestbased advertising from all selfregulatory members including microsoft oath appnexus and other third party ad networks at the following sites in the us digital advertising alliance daa in europe european interactive digital advertising alliance edaa in canada ad choices digital advertising alliance of canada daac you can control interestbased advertising in windows apps by turning off the advertising id in windows settings more choices do you want personalized ads from other companies questions if you have a privacy question or a question for the chief privacy officer of microsoft please contact us by using our web form we will respond to questions within  days ext personalized ads in this browser off optout is currently unavailable please try again later control the personalized ads setting for this web browser learn more if you want microsoft to show ads that might be relevant to you click on to show “generic” ads click off ext personalized ads wherever i use my microsoft account off sign in to change optout is currently unavailable please try again later control the personalized ads setting that applies when you are signed in on any computer or device with your microsoft account including windows windows phone xbox and other devices learn more if you want microsoft to show ads that might be relevant to you click on to show “generic” ads click off if you choose “generic” ads and use a browser your choice applies to everyone when using that browser as long as you do not clear your cookies ext personalized ads in windows in your windows settings you can turn off personalized ads that appear in apps on this device you’ll still see ads but they won’t be personalized anymore if you have windows  access the charms by touching or moving your pointer to the right edge of the screen click or tap settings and then click or tap change pc settings click or tap privacy and then turn off let apps use my advertising id for experiences across apps if you have windows  click or tap the start button click or tap settings click or tap privacy and then turn off let apps use my advertising id for experiences across apps if you have a windows mobile device go to settings tap on privacy tap on advertising id and then turn off let apps use my advertising id for experiences across apps if you want to turn off personalized ads from microsoft wherever you use your microsoft account including apps on windows windows phone xbox and other devices you can do so by selecting the microsoft account option above ext legal privacy  cookies   microsoft jarrett disbrow  chief operating officer at aytu bioscience inc news home advertising board and executive moves energy health care hedge funds m  a private equity technology you have    free profiles   left this month    start your free trial ➤ hey we noticed youre a relsci pro subscriber would you like to view the page there view on relsci pro ➤ email linkedin facebook google tweet reddit permalink jarrett disbrow chief operating officer at aytu bioscience inc overview in the news relationships paths education career history boards  committees investments public holdings transactions jarrett disbrow chief operating officer at aytu bioscience inc overview age  born  notable companies aytu bioscience inc rosewind corp vyrix pharmaceuticals inc board seats  number of relationships this person is connected to  people in the news see more pr newswire january   aytu bioscience to present at biotech showcase  investor conference pr newswire september   aytu bioscience to present at  biopharm america conference marketline newswire july   aytu bioscience appoints two new board members pr newswire april   aytu bioscience strengthens board with appointment of first independent director pr newswire may   rosewind corporation to present at  marcum microcap conference see full news coverage and complete stories with relsci professional create your news feed see more relationships see details joshua r disbrow chairman  chief executive officer at aytu bioscience inc gary v cantrell chief executive officer at yasoo health inc john a donofrio jr chief financial officer  head of north american business development at merz north america inc james b wiegand president at pinel bay corp michael macaluso founder at ampio pharmaceuticals inc nicholas j leb chief financial officer at analytics  life inc gregory gould chief financial officer secretary  treasurer at aytu bioscience inc carl dockery founder at alpha venture capital management llc jonathan heath mcgrael vice presidentcommercial operations at aytu bioscience inc mark d mcgregor former chief financial officer  secretary at ampio pharmaceuticals inc see  more listings with relsci professional start my free trial ➤ see  more paths to jarrett disbrow jarrett disbrow you connections via relationship science jarrett disbrow sync your contacts to see how you can connect with jarrett disbrow start my free trial ➤ see more educational background bs business management  north carolina state university north carolina state universityofficially north carolina state university at raleighis a public coeducational research university located in raleigh north carolina united states commonly known as nc state or simply state the university is part of the university of north carolina system and is a land sea and space grant institution the university forms one of the corners of the research triangle together with duke university in durham and the university of north carolina at chapel hill career history chief operating officer   current aytu bioscience inc aytu bioscience inc is a specialty pharmaceutical company which focuses on developing and commercialization of novel products for urology with a focus on products addressing vitality sexual wellness and reproductive health the company provides prostascint a biologic imaging agent indicated for the diagnostic staging of prostate cancer patients and diagnostic products aytu bioscience was founded on april   and is headquartered in englewood co chief operating officer secretary  treasurer   prior rosewind corp rosewind corp operates offshore sailing school its curriculum consists of a fast track experience for up to two student sailors who voyage for a week or more and topics include marine environment and safety at sea life rafts and ditch bags medical preparedness and fist aid features of offshore capable vessels rigging and deck gear and other rosewind was founded on august   and is headquartered in loveland co president chief executive officer  director    vyrix pharmaceuticals inc vyrix pharmaceuticals inc operates as a clinicalstage biopharmaceutical company it maximizes the clinical and commercial potential of its latestage sexual dysfunction products the company is currently focused on advancing the development of zertane™ for premature ejaculation pe in the us and around the world vyrix pharmaceuticals was founded on november   and is headquartered in greenwood village co manager    eurus pharma llc founder   prior arbor pharmaceuticals llc arbor pharmaceuticals llc engages in the development of pharmaceutical products for pediatricians the firm is a specialty pharmaceutical company currently focused on the cardiovascular hospital and pediatric markets as well as generics through its wilshire division it develop both new chemical entities as well as already approved molecules for new indications or in improved dosage forms the company was founded by jarrett t disbrow and edward j schutter in april  and is headquartered in atlanta ga headmarketing    accentia biopharmaceuticals inc accentia biopharmaceuticals inc engages in the commercialization of patentprotected disruptive healthcare technologies it offers products under the biovaxid revimmune and sinunase brands the company was founded in  and is headquartered in tampa fl headmarketing prior teamm pharmaceuticals inc teamm pharmaceuticals inc part of accentia biopharmaceuticals inc is a company headquartered in morrisville nc that markets and sells prescription pharmaceutical products it was founded by nicholas j leb on  apr  accentia biopharmaceuticals inc acquired teamm pharmaceuticals inc for  million professional prior glaxosmithkline plc ‘glaxosmithkline plc is a global healthcare company which engages in developing manufacturing and marketing of pharmaceutical products including vaccines over the counter medicines and healthrelated consumer products it operates through the following segments pharmaceuticals pharmaceuticals rd vaccines and consumer healthcare the pharmaceuticals business researches develops and makes available medicines that treat a variety of serious and chronic diseases the vaccines business produces pediatric and adult vaccines to prevent a range of infectious diseases including hepatitis a and b diphtheria tetanus and whooping cough measles mumps and rubella polio typhoid influenza and bacterial meningitis the consumer healthcare business markets a range of consumer health products based on scientific innovation the company was founded on december   and is headquartered in brentford united kingdom president  chief executive officer of vyrix pharmaceuticals prior ampio pharmaceuticals inc ampio pharmaceuticals inc is a biopharmaceutical company that engages in the development of therapies to treat prevalent inflammatory conditions its product pipeline includes new uses for approved drugs and new molecular entities for important therapeutic areas including metabolic disease eye disease kidney disease inflammation sexual dysfunction and cns disease the company was founded by david baror in april  and is headquartered in greenwood village co boards  committees corporate boards ▾ member board of directors    aytu bioscience inc aytu bioscience inc is a specialty pharmaceutical company which focuses on developing and commercialization of novel products for urology with a focus on products addressing vitality sexual wellness and reproductive health the company provides prostascint a biologic imaging agent indicated for the diagnostic staging of prostate cancer patients and diagnostic products aytu bioscience was founded on april   and is headquartered in englewood co president chief executive officer  director    vyrix pharmaceuticals inc vyrix pharmaceuticals inc operates as a clinicalstage biopharmaceutical company it maximizes the clinical and commercial potential of its latestage sexual dysfunction products the company is currently focused on advancing the development of zertane™ for premature ejaculation pe in the us and around the world vyrix pharmaceuticals was founded on november   and is headquartered in greenwood village co investments details hidden arbor pharmaceuticals llc arbor pharmaceuticals llc engages in the development of pharmaceutical products for pediatricians the firm is a specialty pharmaceutical company currently focused on the cardiovascular hospital and pediatric markets as well as generics through its wilshire division it develop both new chemical entities as well as already approved molecules for new indications or in improved dosage forms the company was founded by jarrett t disbrow and edward j schutter in april  and is headquartered in atlanta ga public holdings restricted data only for relsci professional users start my free trial ➤ see more transactions details hidden aytu bioscience inc raised money in a private placement transaction details hidden aytu bioscience inc raised money in a private placement transaction details hidden arbor pharmaceuticals llc raised money in a private placement transaction details hidden arbor pharmaceuticals llc raised money in a private placement transaction other affiliations jarrett disbrow is affiliated with aytu bioscience inc rosewind corp vyrix pharmaceuticals inc eurus pharma llc arbor pharmaceuticals llc accentia biopharmaceuticals inc teamm pharmaceuticals inc glaxosmithkline plc ampio pharmaceuticals inc aytu bioscience inc vyrix pharmaceuticals inc youve reached your  free profiles limit this month upgrade to relsci pro today to enjoy unlimited article views and much more start my free trial ➤ still not convinced check out our full listing of features here are you a relsci pro subscriber login to relsci pro  ➤ not a pro subscriber log in here to manage your alerts keep me signed in login  ➤ forgot your password i have read the lexisnexis terms  conditions sign me up  ➤ management team  aytu bioscience skip to content search for search search for search management teamour life sciences experience spans decades josh disbrowchairman  chief executive officerjosh disbrow has been in the life sciences industry for over twenty years across pharmaceuticals diagnostics and medical devices prior to forming aytu bioscience josh was the chief operating officer of ampio pharmaceuticals nyse mkt ampe and led the luoxis diagnostics subsidiary luoxis was merged into aytu in april  following luoxis’ development of the technology behind the company’s mioxsys in vitro diagnostic platform prior to joining ampio in  he served as vice president of commercial operations at arbor pharmaceuticals josh began as arbor’s second employee and oversaw the commercialization of the company’s first product scaling the commercial organization to over  people across sales marketing payer markets distribution commercial operations and national accounts in less than four years arbor grew from a company without any product revenues to a company with net sales of over  million prior to joining arbor he was the director of marketing at liposcience nasdaq lpdx a cardiovascular in vitro diagnostic company josh also served in sales management at cyberonics now livanova plc nasdaq livn a medical device company commercializing implantable neuromodulation devices josh started his career at glaxo wellcome now glaxosmithkline plc holding positions in both sales and marketing he has a master of business administration from wake forest university and bachelor of science in management from north carolina state university read morejarrett disbrowchief operating officerjarrett disbrow is a seasoned pharmaceutical entrepreneur having been the founder of three pharmaceutical and life sciences companies over the past decade and broad industry experience spanning over twenty years most recently and prior to forming aytu bioscience in april  jarrett was the president  ceo of vyrix pharmaceuticals a specialty pharmaceutical company focused on male sexual dysfunction mr disbrow’s first pharmaceutical startup was arbor pharmaceuticals a company focused initially on pediatrics as the sole founder of arbor jarrett was responsible for the vision fundraising startup strategy and growth of the company until the acquisition by an investor group in  prior to founding arbor pharmaceuticals he was head of marketing for accentia biopharmaceuticals inc jarrett began his career with glaxowellcome now glaxosmithkline plc where he held various roles in sales and marketing he received a bs in business management from north carolina state university in raleigh nc read moregregory gouldchief financial officer treasurer and secretarygreg gould has held senior management positions in the life sciences industry for over  years prior to joining aytu bioscience on a fulltime basis he split his time between aytu and ampio pharmaceuticals inc from april  until june  prior to joining ampio pharmaceuticals in june  he provided financial and operational consulting services to the biotech industry through his consulting company gould llc mr gould was chief financial officer treasurer and secretary of seracare life sciences from november  until the company was sold to linden capital partners in april  during the period from july  until april  mr gould also served as the interim president and chief executive officer of seracare mr gould has held several other executive positions at publicly traded life sciences companies including the chief financial officer role at atrix laboratories inc an emerging specialty pharmaceutical company focused on advanced drug delivery during mr gould’s tenure at atrix he was instrumental in the negotiation and sale of the company to qlt inc for over m he also played a critical role in the management of several licensing agreements including the global licensing agreement with sanofisynthelabo of the eligard® product line mr gould was the chief financial officer at colorado medtech inc a publicly traded medical device design and manufacturing company where he negotiated the transaction to sell the company to krg capital partners mr gould began his career as an auditor with arthur andersen llp he currently serves on the board of directors of cytodyn inc a publicly traded drug development company pursuing antiviral agents for the treatment of hiv mr gould graduated from the university of colorado with a bs in business administration and is a certified public accountant read more aytu bioscience adds ceo josh disbrow and coo jarrett disbrow to the board of directors email protected twitterlinkedin about our vision our mission our team our values our partners faq terms  conditions privacy policy board news latest board news board news by location… europe usa  canada middle east all the others board news by company type public  listed vc  pe backed privately held trust  fund  reit board news by industry… life sciences  health care financials information technology women on board submit a press release board directory company press releases public  listed global  fortune  private or vc  pe backed unicorns trust  fund newsletter contact log in register select pageabout    our vision our mission     our team     our values     our partners     faq     terms  conditions     privacy policy board news    latest board news     board news by location…        europe         usa  canada         middle east         all the others     board news by company type        public  listed         vc  pe backed         privately held         trust  fund  reit     board news by industry…        life sciences  health care         financials         information technology     women on board     submit a press release board directory    company press releases     public  listed     global      fortune      private or vc  pe backed     unicorns     trust  fund newsletter contact log in register homeboard  usa  can board listedpublic companies aytu bioscience adds ceo josh disbrow and coo jarrett disbrow to the board of directors aytu bioscience adds ceo josh disbrow and coo jarrett disbrow to the board of directors january   by talentboards team comments are off board  usa  can board listedpublic companies – usa co – aytu bioscience inc otcqx aytu a specialty healthcare company focused on commercializing treatments for urological and related conditions today announced that josh disbrow aytu’s chief executive officer and jarrett disbrow aytu’s chief operating officer have been added to the aytu board of directors the two will join michael macaluso who remains on the board as the company’s sole independent director josh disbrow aytu’s chief executive officer stated “the initial expansion of our board of directors is in line with other moves aytu has made to accelerate our growth and establish a leadership position as a specialty healthcare company focused on urology we have built a strong commercial foundation bringing in two commercial stage products and rapidly building a sales and marketing team to propel their growth further we are advancing toward global commercialization of mioxsys™ which is now ce marked and under clinical development in the united states with the initial board members now in place we expect to further develop our leadership team with additional directors that will help ensure that our assets will be maximized in conjunction with our appointments we have begun the process of recruiting independent board directors to augment our team we look forward to providing updates as we appoint additional board members in the near future” josh disbrow and jarrett disbrow were the founding management team at arbor pharmaceuticals and served as vice president of commercial operations and presidentceo respectively until the company’s acquisition in  since exiting arbor and prior to the formation of aytu bioscience in april  josh disbrow served as coo of ampio pharmaceuticals and ceo of ampio subsidiary luoxis a specialty biotechnology company prior to that he held commercial roles at liposcience cyberonics and glaxosmithkline most recently jarrett disbrow held the position of ceo of vyrix pharmaceuticals a specialty pharmaceutical company focused on male sexual dysfunction as well as prior commercial roles at accentia pharmaceuticals and glaxosmithkline about aytu bioscience inc aytu bioscience inc is a commercialstage specialty healthcare company focused on urological and related conditions the company’s products include fdaapproved prostascint® capromab pendetide a radiolabeled monoclonal antibody that targets prostate specific membrane antigen psma a protein highly expressed by prostate cancer as well as primsol® trimethoprim oral solution the only fdaapproved oral solution of trimethoprim the standard therapy for urinary tract infections aytu’s strategy is to continue building its portfolio of revenuegenerating urology products and latestage development assets leveraging its commercial team and expertise to further build those brands within wellestablished markets  disclaimer  news data and statement included in this release are intended exclusively for information purposes product and brand names used in this release maybe trademarks or registered trade marks of their respective owners talentboards accepts neither liability for the consequences of the reader’s reliance nor responsibility for the adequacy or accuracy of this release no data or statement in this release should be considered a recommendation for the purchase retention or sale of the securities referred to hereinother related postsmercury systems adds lisa disbrow and ml krakauer to the board as independent directorskempharm appoints david tierney to the board of directorsvensun pharmaceuticals appoints ed schutter to the board of directorstalentboards teamhere the original post  comments are closed latest boardroom news standard chartered announces dr ngozi okonjoiweala to its board as upcoming independent nonexecutive director july   tristar resources appoints mark wellesleywood as executive chairman july   pacific city financial appoints sang lee as new chairman of the board of directors july   medallion financial adds john everets to its board as independent director july   morgan stanley announces board member tom glocer as upcoming independent lead director july   random boardsdawn capitalcst brandscatchpoint systemsbceunitrends    talentboards inc  all rights reserved  geneva  miami  london  boston  paris  shanghai  monaco  arbor pharmaceuticals inc jarrett t disbrow a publisher of business information since         search business search executive   advanced search      sign in    hints company name arbor pharmaceuticals inc  address  falls of the neuse rd ste  raleigh  united states email infoarborpharmacom phone  website wwwarborpharmacom fax na             summary                   executive details       business information the groups principle activity is to serve the pharmaceutical needs of the growing pediatric population the group also develop clinical utility of the product the groups product includes zinotictm the group operates from united states executive information name title email jarrett disbrowceo pres na eric barnettcfo na john donofriovp  operations controller na josh disbrowvp  commercial operations na rich francovp  marketing na   company size sales range below  millon employee range below      to see complete results subscribe now to see complete results subscribe now click for more executives        financial summary                income statement                  balance sheet                   cash flows                    ratios           for subscribers onlyclick here to subscribe now             home    about us    product information     subscription    list builder     executive list     email lists     contact us    site map    browse directory    nbsp   walkerss research  a publisher of business information since  all rights reserved